Vireo Growth Inc. (VREOF)
OTCMKTS · Delayed Price · Currency is USD
0.6800
+0.0020 (0.29%)
Oct 16, 2025, 4:00 PM EDT
Vireo Growth Revenue
Vireo Growth had revenue of $48.06M in the quarter ending June 30, 2025, with 91.42% growth. This brings the company's revenue in the last twelve months to $122.79M, up 25.24% year-over-year. In the year 2024, Vireo Growth had annual revenue of $99.38M with 12.77% growth.
Revenue (ttm)
122.79M
Revenue Growth
+25.24%
P/S Ratio
5.29
Revenue / Employee
261.26K
Employees
520
Market Cap
649.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 99.38M | 11.25M | 12.77% |
| Dec 31, 2023 | 88.13M | 13.51M | 18.10% |
| Dec 31, 2022 | 74.63M | 20.18M | 37.06% |
| Dec 31, 2021 | 54.45M | 5.23M | 10.64% |
| Dec 31, 2020 | 49.21M | 19.26M | 64.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Jushi Holdings | 256.36M |
| Nuo Therapeutics | 1.95M |
Vireo Growth News
- 2 days ago - Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze - GlobeNewsWire
- 14 days ago - Vireo Growth Inc. Enters into Definitive Agreements to Acquire Outstanding Senior Secured Convertible Notes of Schwazze - GlobeNewsWire
- 4 weeks ago - Vireo Growth Inc. Announces Launch of Adult-Use Cannabis Sales in Minnesota - GlobeNewsWire
- 6 weeks ago - Vireo Growth Inc. Comments on Recent Market Activity; Company Unaware of Any Material Change - GlobeNewsWire
- 2 months ago - Vireo Growth Inc. (VREOF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vireo Growth Inc. Completes Loan Refinancing and Upsize With a Bank Led Syndicate Arranged by CEO, John Mazarakis - GlobeNewsWire
- 3 months ago - Vireo Growth Inc. and Curio Wellness Announce Manufacturing and Distribution Partnership - GlobeNewsWire
- 4 months ago - Vireo Growth Inc. Announces Closing of Proper Brands Acquisition in Missouri - GlobeNewsWire